TBPH - דינמיקת הכנסות משנה לשנה ב-12 החודשים האחרונים Theravance Corp

Theravance Biopharma (TBPH) is implementing robotic packaging and AI-driven documentation audits. This chart of year-over-year sales volume changes for the LTM captures this trend, where the current value is 34.80. The business model relies on outsourcing drug production to third-party plants, while financial stability is maintained through regular royalty payments from partners, which minimize operating expenses.
Theravance Biopharma, Inc. - פילוחים אנליטיים ומדדי מפתח (TBPH)

Stable raw material supplies and the humanitarian status of Theravance Biopharma (TBPH) respiratory products minimize external risks, creating a predictable foundation for commercialization. This annual revenue growth over a rolling period smooths out quarterly volatility, allowing investors to assess the actual trajectory of business expansion and timely identify growth deceleration preceding a potential correction in the asset's value.